These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6329607)

  • 61. In-vivo evaluation of ofloxacin in Salmonella typhimurium infection in mice.
    Fu KP; Hilliard J; Isaacson D; Tobia AJ; Rosenthale ME; McGuire JL
    J Antimicrob Chemother; 1990 Feb; 25(2):263-8. PubMed ID: 2184159
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of experimental Salmonella typhimurium infection with mecillinam and ampicillin.
    Butler T; Shuster CW; Dixon P
    Antimicrob Agents Chemother; 1981 Feb; 19(2):328-31. PubMed ID: 6289730
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Trifluoperazine: a broad spectrum bactericide especially active on staphylococci and vibrios.
    Mazumder R; Ganguly K; Dastidar SG; Chakrabarty AN
    Int J Antimicrob Agents; 2001 Oct; 18(4):403-6. PubMed ID: 11691578
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intracellular visualization of ampicillin-loaded nanoparticles in peritoneal macrophages infected in vitro with Salmonella typhimurium.
    Pinto-Alphandary H; Balland O; Laurent M; Andremont A; Puisieux F; Couvreur P
    Pharm Res; 1994 Jan; 11(1):38-46. PubMed ID: 8140054
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of experimental Salmonella typhimurium infection in mice with fleroxacin.
    Butler T; Jacobs MR; Farhi D
    Antimicrob Agents Chemother; 1988 May; 32(5):791-2. PubMed ID: 3134853
    [No Abstract]   [Full Text] [Related]  

  • 66. Oral ciprofloxacin treatment for Salmonella typhimurium infection of normal and immunocompromised mice.
    Brunner H; Zeiler HJ
    Antimicrob Agents Chemother; 1988 Jan; 32(1):57-62. PubMed ID: 2964809
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Use of plasmid profiles in epidemiologic surveillance of disease outbreaks and in tracing the transmission of antibiotic resistance.
    Mayer LW
    Clin Microbiol Rev; 1988 Apr; 1(2):228-43. PubMed ID: 2852997
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles.
    Fattal E; Youssef M; Couvreur P; Andremont A
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1540-3. PubMed ID: 2684009
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cefotaxime. An update of its pharmacology and therapeutic use.
    Todd PA; Brogden RN
    Drugs; 1990 Oct; 40(4):608-51. PubMed ID: 2083516
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Susceptibility of 50 isolates of Clostridium perfringens to cefotaxime, fosfomycin, penicillin G and vancomycin; variable tolerance for vancomycin.
    Jung WK
    Chemotherapy; 1983; 29(2):99-103. PubMed ID: 6301777
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Comparative efficacy of ampicillin, chloramphenicol, cefotaxime, ceftriaxone and pefloxacin in experimental Salmonella typhimurium infection].
    Nauciel C; Martin E
    Pathol Biol (Paris); 1987 Nov; 35(9):1239-42. PubMed ID: 3320900
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Improvement of the therapeutic efficacy of fosfomycin by addition of glucose-6-phosphate in the treatment of intraperitoneally infected mice (author's transl)].
    Hirschl A; Stanek G; Rotter M
    Zentralbl Bakteriol A; 1980; 246(4):562-6. PubMed ID: 6999793
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Value addition in the efficacy of conventional antibiotics by Nisin against Salmonella.
    Singh AP; Prabha V; Rishi P
    PLoS One; 2013; 8(10):e76844. PubMed ID: 24116175
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chemotherapeutic efficacy of cefotaxime and failure of fosfomycin in murine Salmonella typhimurium infection.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1984; 30(3):148-57. PubMed ID: 6329607
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.